Autopsy report · NCT01301118

Graft Take and Microbiology in Burns

“Technical problems with protocol.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months after it had already started.
• Suspended: paused, and may or may not restart.
• 30 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Sponsor

Federal University of São Paulo

Sponsor type

University, hospital or other

Conditions

Transplantation Infection; Wound of Skin; Burns; Graft Loss; Infection

Participants

30 (planned, not actual)

Trials that died the same way

• Bacteriophage Therapy in Patients With Prosthetic Joint Infections
  “Changes to protocol design” (73% match in meaning)
• Adjunctive Treatment With Vitamin D3 in Patients With Active IBD
  “Protocol is being modified.” (70% match in meaning)
• Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant
  “Replaced by another protocol” (69% match in meaning)
• The TANTALUS® II System for the Treatment of Type 2 Diabetes: A Randomized Study
  “Protocol design under review.” (69% match in meaning)
• A Phase 3 Study to Evaluate the Efficacy and Safety of Resiniferatoxin for Pain Due to Osteoarthritis of the Knee
  “To be replaced by a different protocol” (68% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.